BLOODPAC's mission is to accelerate the development, validation and accessibility of liquid biopsy assays to improve the outcomes of patients with cancer. To do so, we lead a collaborative infrastructure that enables sharing of information between stakeholders in public, industry, academia and regulatory agencies.